April 15th 2025
One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.
A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.
April 8th 2025
How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.
April 4th 2025
The parties aim to create an end-to-end digital thread that links research data all the way through to life sciences manufacturing.
April 3rd 2025
In a move meant to encourage domestic production, the president’s executive order features a 10% baseline tax, expected to take effect April 9.
US biopharma industry: 854,000 jobs, $1.2 trillion in total economic output
PhRMA-sponsored study outlines the economic effects of US-based operations
Cigna negotiates first performance-based contracts for PCSK9 drugs
Deals with Amgen and Sanofi/Regeneron enhance new pricing policies for specialty drugs
2016 EMD Serono Specialty Digest: health plans’ ongoing cost struggle
Managed care organizations are adjusting rapidly to onslaught of specialty products
Specialty pharmacy dynamics
The SP channel continues to grow, with manufacturers looking for more control over access
A Conversation with Mark Merritt, Pharmaceutical Care Management Association
IMS Health and Quintiles to merge
Both clinical research and commercial analytics markets to be served by combination
Another tough week for pharma on drug pricing policy
More healthcare stakeholders line up against the industry
Abbott bets on medical devices with $25-billion acquisition of St. Jude Medical
Better access to hospital systems is a goal; pharmaceutical business is fading
IMS 2015 Use of Medicines report: US sales reach $424.8 billion
Double-digit growth (12.2%) for the second year running
Pfizer cancels merger with Allergan; hey, what about Inflectra biosimilar?
US tax rules scuttle merger, while the US' second biosimilar wins FDA approval
Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute
Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians
Walgreens and OptumRx partnership: more consolidation in retail pharmacy
Partnership combines mail-order PBM with brick-and-mortar drugstores
Express Scripts 2015 Drug Trend: not so bad in drug price escalation
Annual report highlights company's cost-control measures
Spectra Selling Solutions: a new player in contract sales organizations
New subsidiary of The Medical Affairs Co. hopes to fill gaps in CSO offerings
Use data analytics to monitor 340B discount drug pricing
Discerning how and where products are discounted is an expensive headache for manufacturers
A Conversation with Matt Wallach, Veeva Systems
Bringing value to healthcare: practical steps for getting to a market-based model
A new, market-driven model of drug development and commercialization is appearing*
A case study in differing approaches to reimbursement approval in Europe and the US
Looking at 'cost' and 'value' under different evaluation processes
With private-equity help, Inmark moves deeper into pharma cold chain packaging
Quad-C investment will enable future acquisitions
McKesson commits $3.1 billion to acquire Canadian pharmacies and US oncology services
Canada's Rexall chain, plus Biologics, Inc, and Vantage Oncology
Donald Trump is no friend of the pharma industry
New healthcare proposals re-open talk of drug importation
IFPW initiates its charitable efforts in Africa with GAVI
Global drug-wholesaler group plans future educational and developmental work
Managing logistics partnerships in uncertain times
Outsourced services can provide significant financial and risk-avoidance benefits
Logistics providers confront a complex, global healthcare market
The rise in product volume is more than matched by the rise of regulatory constraints
Pharma logistics--so what?
Looking at the essential value of well-managed supply chains
Executive pharma management is playing catch-up with digital technologies
IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets
Collaboration key to a healthy supply chain in 2016
HDMA seeks to encourage more outreach to business partners and government
A Conversation with Bill Roth, Blue Fin Group
CMS publishes the long-awaited AMP rule
'Average Manufacturer Price' is now a mostly settled matter
Annual EY Firepower report finds a 'feverish' environment for M&A
Deal value soared above $300 billion in 2015, but will the dealmaking sustain Big Pharma companies?